We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

As recently as five years ago, China was a bit player in biotechnology as their percentage of worldwide clinical trial ...

Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Cerus in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now forecasts that the ...

Africa is at a pivotal moment in its journey toward sustainable development, with healthcare and biotechnology emerging as ...

Biotechnology venture capital is recovering from its slide and investors are expressing optimism about 2025, even as they ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Reliever Tanner Scott’s $72 million, four-year contract with the Los Angeles Dodgers includes $21 million in deferred ...

YZi Labs announced it changed its company name from Binance Labs to operate independently. The firm will expand its ...